home / stock / imun / imun quote
Last: | $0.093 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.093 |
High: | $0 |
Low: | $0 |
Volume: | 12 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.093 | $0 | $0.093 | $0 | $0 | 12 | 10-19-2023 |
$0.093 | $0.093 | $0.093 | $0.093 | $0.093 | 1,830 | 10-18-2023 |
$0.1 | $0 | $0.1 | $0 | $0 | 136 | 10-17-2023 |
$0.1 | $0 | $0.1 | $0 | $0 | 5 | 10-12-2023 |
$0.1 | $0.072 | $0.1 | $0.1 | $0.072 | 1,201 | 10-11-2023 |
$0.0997 | $0.0997 | $0.0997 | $0.0997 | $0.0997 | 498 | 10-10-2023 |
$0.09675 | $0.072 | $0.09675 | $0.09675 | $0.072 | 1,238 | 10-09-2023 |
$0.0994 | $0 | $0.0994 | $0 | $0 | 52 | 10-06-2023 |
$0.0994 | $0.0994 | $0.0994 | $0.0994 | $0.0994 | 1,000 | 10-05-2023 |
$0.1 | $0 | $0.1 | $0 | $0 | 1 | 10-02-2023 |
$0.1 | $0 | $0.1 | $0 | $0 | 1 | 09-27-2023 |
$0.1 | $0 | $0.1 | $0 | $0 | 15 | 09-26-2023 |
$0.1 | $0.1 | $0.1 | $0.1 | $0.1 | 3,000 | 09-22-2023 |
$0.0949 | $0.0949 | $0.0949 | $0.0949 | $0.0949 | 133 | 09-20-2023 |
$0.0824 | $0.0824 | $0.0824 | $0.0824 | $0.0824 | 201 | 09-19-2023 |
$0.071 | $0.13 | $0.071 | $0.13 | $0.06675 | 102,394 | 09-18-2023 |
$0.15 | $0 | $0.15 | $0 | $0 | 1 | 09-15-2023 |
$0.15 | $0.15 | $0.15 | $0.15 | $0.15 | 5,500 | 09-14-2023 |
$0.145 | $0.17 | $0.145 | $0.17 | $0.13 | 2,900 | 09-13-2023 |
$0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 13,000 | 09-12-2023 |
News, Short Squeeze, Breakout and More Instantly...
Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC Pink: IMUN) (“Biostax”), a hub and spoke biotech development engine, sadly announces the passing of H. Louis Salomonksy, a dedicated member of its Board of Directors. Mr. Salomonksy pas...
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp . (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine, announces the signing of a research collaboration agreement with Immgenuity, Inc . The joint resear...
Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) ("Biostax"), a hub-and-spoke biotech development engine, announces that they have accepted the transfer of three Investigational New Drug Applications (IND) for the drug candidate, JKB-12...